Purple Biotech
PPBT
6 hedge funds and large institutions have $758K invested in Purple Biotech in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 4 closing their positions.
16% more capital invested
Capital invested by funds: $651K → $758K (+$107K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
25% less funds holding
Funds holding: 8 → 6 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Advisor Group
Phoenix,
Arizona
|
+$237K |
| 2 |
MC
Menta Capital
San Francisco,
California
|
+$69.6K |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$62.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.96K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$115K |
| 2 |
Jane Street
New York
|
-$49K |
| 3 |
FMA
FNY Managed Accounts
New York
|
-$17.4K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$7K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MC
1
Menta Capital
San Francisco,
California
| $257K | +$69.6K | +10 | +32% |
|
|
AG
2
Advisor Group
Phoenix,
Arizona
| $239K | +$237K | +34 | +850% |
|
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $175K | – | – | – |
|
|
RJA
4
Raymond James & Associates
St Petersburg,
Florida
| $57K | +$62.7K | +9 | New |
|
5
Creative Planning
Overland Park,
Kansas
| $24K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $5K | +$6.96K | +1 | New |
|
|
MIFH
7
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
| $1K | – | – | – |
|
|
VKH
8
Virtu KCG Holdings
New York
| – | -$115K | -17 | Closed |
|
|
9
Jane Street
New York
| – | -$49K | -7 | Closed |
|
|
FMA
10
FNY Managed Accounts
New York
| – | -$17.4K | -3 | Closed |
|
|
11
Wells Fargo
San Francisco,
California
| – | -$7K | -1 | Closed |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| – | -$1K | – | – |
|
PPBT Hedge Fund Activity: Q4 2016 in Review
6 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q4 2016, worth a combined $758K — up 16% from $651K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PPBT and 2 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Advisor Group, adding an estimated $237K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $115K sold.
- 6 institutional investors held Purple Biotech (PPBT) as of Q4 2016, down from 8 in Q3 2016.
- Funds reported $758K of Purple Biotech stock for Q4 2016, up 16% quarter-over-quarter.
- 2 funds opened new Purple Biotech positions in Q4 2016 and 4 closed out, a net change of -2 holders.
- The largest Purple Biotech buyer in Q4 2016 was Advisor Group, an estimated $237K added.
- The largest Purple Biotech seller in Q4 2016 was Virtu KCG Holdings, an estimated $115K sold.
Based on aggregated 13F filings for Q4 2016.